New drug duo aims to halt Tough-to-Treat lung cancer
NCT ID NCT04497584
Summary
This study is testing whether combining two existing drugs, afatinib and prednisone, can help control advanced squamous non-small cell lung cancer in patients whose cancer has grown despite prior treatments. The goal is to see if this combination can slow the cancer's progression and is safe for patients. It is a small, early-phase trial for adults with this specific type of lung cancer who have not tried certain other medications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SQUAMOUS NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UT Southwestern Medical Center
Dallas, Texas, 75390, United States
Conditions
Explore the condition pages connected to this study.